Cite
HARVARD Citation
Sato, H. et al. (2018). Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer. Cancer science. 109 (10), pp. 3183-3196. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sato, H. et al. (2018). Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer. Cancer science. 109 (10), pp. 3183-3196. [Online].